Healthy Volunteers Clinical Trial
Official title:
The Multi-center Normal Reference Study of Carotid Artery Ultrafast Pulse Wave Velocity (UFPWV) in Chinese Han Adults (CAR-PWV Study)
To establish the range of BS and ES (m/s) of normal carotid artery by using ultrafast pulse wave velocity (UFPWV), and to explore the influencing factors.
With the gradual aging of Chinese population and continuous development of economy and
society, the incidence of cardiovascular disease and the number of patients have increased
rapidly. The National Heart Center has reported that the number of patients with clinically
diagnosed cardiovascular disease in China has reached 290 million in 2016 (240 million in
2014). Cardiovascular disease is the most common cause of death in humans, accounting for
nearly 60% of all deaths worldwide. The updated data from World Health Organization (WHO) in
2008 have shown that atherosclerosis and hypertension are the major diseases of the
cardiovascular system. Therefore, early detection of arteriosclerosis, timely treatment and
early evaluation of therapeutic efficacy are of great significance for the overall control
and reduction of the incidence and mortality of cardiovascular disease.
Carotid artery intima-media thickness (IMT) is often used to evaluate early atherosclerosis,
but IMT reflects the change of vascular wall structure. In the early stage of
atherosclerosis, the changes of vascular elasticity and resistance occur earlier than those
of arterial wall thickening. Therefore, accurate evaluation of vascular function plays an
important role in the early diagnosis of atherosclerosis.
Basic and clinical studies and clinical data have shown that pulse wave velocity (PWV) is a
reliable index for early evaluation of atherosclerosis. The blood is pumped from the left
ventricle during systole, and travels along the arterial system to form pulse wave. Its
propagation velocity between two fixed points is the PWV. Atherosclerosis leads to the
increased PWV. The detection of PWV can accurately reflect the distensibility and stiffness
of arterial wall, thereby early detecting atherosclerosis.
There are three main methods for non-invasive pulse wave measurement: Photoelectric sensor is
used to measure and record photoplethysmography signal. Pressure sensor is utilized to record
pressure wave signals produced by arterial pulsation on the body surface. Ultrasonic Doppler
sensor is applied to collect photoplethysmography signal. Photoelectric sensor acquisition
system is difficult to distinguish the pulse waves between the large artery and the capillary
arteriole, cannot detect the signal of the deep aorta, is easily affected by the electrical
signals of perivascular tissue, and has not been widely used in the clinic. Pressure sensor
can be used to collect pressure wave signals, such as brachial-ankle pulse wave. This method
has relatively low cost, is often used in clinic, but cannot directly get the pulse wave form
and the distance of blood vessel, has many influencing factors and low accuracy. Ultrasonic
Doppler technique, such as Echo Tracking and QSA, can reveal deep vein pulse waveforms.
However, limited by the traditional ultrasonic processing platform, signal acquisition and
formula calculation are complex, and the repeatability is poor. Therefore, the clinical
application value is limited. It is urgent to establish a new, simple and precise method for
the detection of PWV.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |